These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1283506)

  • 1. Neuroleptic malignant syndrome-like state in a patient with Down syndrome and basal ganglia calcification.
    Komatsu H; Nishimura A; Okano S; Miyanomae Y; Takeuchi Y; Sawada T
    Brain Dev; 1992 Nov; 14(6):400-3. PubMed ID: 1283506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early disappearance of calcification in posterior paraspinal muscles in a patient with rhabdomyolysis associated with neuroleptic malignant syndrome.
    Sasaki H; Ishii K; Kono AK; Miyamoto N; Fukuda T; Kanata J; Kita Y
    Radiat Med; 2006 Jul; 24(6):463-6. PubMed ID: 16958430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major symptoms and differential diagnosis of neuroleptic malignant syndrome: three case reports.
    Védie C; Poinso F; Hemmi F; Rivet B
    Eur Psychiatry; 2000 Aug; 15(5):334-7. PubMed ID: 10954878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal ganglia calcification and psychosis in Down's syndrome.
    Thase ME
    Postgrad Med J; 1984 Feb; 60(700):137-9. PubMed ID: 6231537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic malignant syndrome: a study of CSF monoamine metabolism.
    Nisijima K; Ishiguro T
    Biol Psychiatry; 1990 Feb; 27(3):280-8. PubMed ID: 1689186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isocratic analysis of 3-methoxy-4-hydroxyphenyl glycol, 5-hydroxyindole-3-acetic acid and 4-hydroxy-3-methoxyphenylacetic acid in cerebrospinal fluid by high-performance liquid chromatography with amperometric detection.
    Bottiglieri T; Lim CK; Peters TJ
    J Chromatogr; 1984 Nov; 311(2):354-60. PubMed ID: 6084013
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical course and CSF monoamine metabolism in neuroleptic malignant syndrome--a study of nine typical cases and five mild cases].
    Nishijima K; Ishiguro T
    Seishin Shinkeigaku Zasshi; 1989; 91(6):429-56. PubMed ID: 2479043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Norepinephrine metabolism in the central nervous system of man: studies using 3-methoxy-4-hydroxyphenylethylene glycol levels in cerebrospinal fluid.
    Chase TN; Gordon EK; Ng LK
    J Neurochem; 1973 Sep; 21(3):581-7. PubMed ID: 4270247
    [No Abstract]   [Full Text] [Related]  

  • 9. [Monoamine imbalance of the central nervous system in a case of Shy-Drager syndrome with recurrent attacks of a neuroleptic malignant syndrome].
    Ueda M; Hamamoto M; Otsubo K; Miyazaki T; Terashi A
    Rinsho Shinkeigaku; 1996 May; 36(5):696-8. PubMed ID: 8905993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid monoamine metabolism in a case of neuroleptic malignant syndrome improved by electroconvulsive therapy.
    Nisijima K; Oyafuso K; Shimada T; Hosino H; Ishiguro T
    Biol Psychiatry; 1996 Mar; 39(5):383-4. PubMed ID: 8704073
    [No Abstract]   [Full Text] [Related]  

  • 11. Myoglobinuria in neuroleptic malignant syndrome.
    Fink RA
    Arch Intern Med; 1985 Sep; 145(9):1736. PubMed ID: 4026506
    [No Abstract]   [Full Text] [Related]  

  • 12. Haloperidol-induced rhabdomyolysis without neuroleptic malignant syndrome in a handicapped child.
    Yoshikawa H; Watanabe T; Abe T; Oda Y; Ozawa K
    Brain Dev; 2000 Jun; 22(4):256-8. PubMed ID: 10838114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic-induced extrapyramidal symptoms with fever. Heterogeneity of the 'neuroleptic malignant syndrome'.
    Levinson DF; Simpson GM
    Arch Gen Psychiatry; 1986 Sep; 43(9):839-48. PubMed ID: 2875701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lesch-Nyhan syndrome: a study of motor behavior and cerebrospinal fluid neurotransmitters.
    Jankovic J; Caskey TC; Stout JT; Butler IJ
    Ann Neurol; 1988 May; 23(5):466-9. PubMed ID: 2455472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basal ganglia calcification and psychosis in mongolism.
    Jakab I
    Eur Neurol; 1978; 17(5):300-14. PubMed ID: 152200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neuroleptic syndrome and central dopamine metabolites.
    Tollefson GD; Garvey MJ
    J Clin Psychopharmacol; 1984 Jun; 4(3):150-3. PubMed ID: 6203936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute renal failure in neuroleptic malignant syndrome].
    Wagner G; Rónai L
    Orv Hetil; 1995 Oct; 136(40):2173-6. PubMed ID: 7566952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental variations in CSF monoamine metabolites during childhood.
    Hedner J; Lundell KH; Breese GR; Mueller RA; Hedner T
    Biol Neonate; 1986; 49(4):190-7. PubMed ID: 2423144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental changes in cerebrospinal fluid concentrations of monoamine-related substances in patients with dentatorubral-pallidoluysian atrophy.
    Takeuchi Y; Matsushita H; Sakai H; Kawano H; Ochi M
    J Child Neurol; 2001 Feb; 16(2):79-82. PubMed ID: 11292229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biochemical mechanisms of extrapyramidal-motoric effect of haloperidol in man].
    Eben E; Ackenheil M; Raese J; Rüther E
    Arzneimittelforschung; 1974 Aug; 24(8):1133-5. PubMed ID: 4479374
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.